Source: iQoncept / Shutterstock
Day One Biopharmaceutical (NASDAQ:DAWN) just reported results for the first quarter of 2024.
- Day One Biopharmaceutical reported earnings per share of -72 cents. This was below the analyst estimate for EPS of -66 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/dawn-stock-earnings-day-one-biopharmaceutical-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC